Re: Sweden's HRT and breast cancer study

From: art fougner, md (evsono@pipeline.com)
Fri May 12 07:37:39 2006


One area that still needs to be researched and that may suggest that Swedish results can't be easily extrapolated to US is Genetic Background. Studies incoporating BRCA 1,2, and so on desperately need to be done to see the background risks of the population studied.

Thanks for posting this informative article.

Art

At Fri, 12 May 2006, GIN11153@aol.com wrote: >
>Menopausal Hormone Therapy and Other Breast Cancer Risk Factors in Relation
>to the Risk of Different Histological Subtypes of Breast Cancer: A
>Case-control Study
>_http://www.obgyn.net/bh/bh.asp?page=/bh/articles/menopausal_hormone_therapy_
>(http://www.obgyn.net/bh/bh.asp?page=/bh/articles/menopausal_hormone_therapy)
>
>Gail Neuman RNC CPHW SNP LNC
>student nurse practitioner and student midwife
>listowner of LegalNurseConsulting@yahoogroups.com
>certified high risk OB/legal nurse consultant
>Perinatal Nurse Associates
>Notary Public/Certified Loan Signing Agent
>PrePaid Legal Sales Associate
>Santa Ana, CA

--
art fougner, md
Support Free Speech
Buy Danish!




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 05:03:04 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.